Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

IPAR vs EPC: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

IPAR Wins Head-to-Head Institutional Verdict (4–1 across 6 Pillars · 7–3 Matrix Metrics)

IPAR Overall Winner 6-Pillar Tally: IPAR 4 – 1 EPC (1 Tie) Matrix Metrics: IPAR 7 – 3 EPC

As of Nov 16, 2026, Interparfums, Inc. (IPAR) is the stronger overall head-to-head candidate over Edgewell Personal Care Company (EPC) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). IPAR carries a Unified Composite Score of 31.7/100 (SELL) at $133.94 (26.2x Forward P/E, 17.9% operating margin), whereas EPC carries 42.0/100 (HOLD) at $27.27 (13.8x Forward P/E, 7.9% operating margin).

  • Composite vs. Pillar Nuance: While EPC currently prints a higher short-term Unified Composite Score (42.0/100 HOLD vs. IPAR 31.7/100 SELL), IPAR captures the overall institutional head-to-head verdict (7–3 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (17.9% vs. 7.9% operating margin) and revenue trajectory (+0.0% vs. -9.9% YoY).
  • Technical & Structure Timing Caution: IPAR trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 68.9); meanwhile EPC is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 44.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About IPAR vs EPC
IPAR NASDAQ Head-to-Head Winner
Interparfums, Inc. Common Stock
Perfumes, Cosmetics & Other Toilet Preparations
$133.94
+0.43% 1D
Market Cap $4.2B
TTM Revenue $1.50B
Forward P/E 26.2x
Beta / 30D Vol 0.02β · 43% Vol
Unified Composite Score
31.7 / 100 SELL
Tech 50.0 Fund 28.0 Flow 50.0 Mom 40.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (2.5% over 20 days), RSI 69
RSI-14: 68.9 · SMA20: $123.59 · SMA50: $117.53
EPC NYSE
Edgewell Personal Care Company
Perfumes, Cosmetics & Other Toilet Preparations
$27.27
-0.04% 1D
Market Cap $1.3B
TTM Revenue $2.00B
Forward P/E 13.8x
Beta / 30D Vol 0.34β · 52% Vol
Unified Composite Score
42.0 / 100 HOLD
Tech 43.0 Fund 41.0 Flow 50.0 Mom 46.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -0.2%) with fading momentum, RSI 45
RSI-14: 44.8 · SMA20: $28.36 · SMA50: $27.79

6-Pillar Scorecard Institutional Category Breakdown (IPAR 4 – 1 EPC)

Columns: Metric · IPAR · EPC
1. Valuation Multiples EPC
Forward P/E 26.2x 13.8x
Trailing P/E 24.6x 14.5x
PEG Ratio 3.20x 2.87x
EV / Revenue 2.8x 0.7x
2. Growth & Scale IPAR
Revenue Growth (YoY) +0.0% -9.9%
Earnings Growth (YoY) +3.9% -53.4%
TTM Revenue (USD) $1.50B $2.00B
Market Cap $4.2B $1.3B
3. Profitability & Quality IPAR
Gross Margin 59.8% 43.4%
Operating Margin 17.9% 7.9%
Net Profit Margin 11.3% -2.6%
Return on Equity (ROE) 19.0% -0.1%
4. Balance Sheet & Cash Flow IPAR
Cash Generation (TTM) $293M EBITDA $235M EBITDA
Cash Flow Margin 19.5% EBITDA Mgn 11.8% EBITDA Mgn
Net Cash / Leverage $27.43 Book/Sh · 19.0% ROE $31.93 Book/Sh · -0.1% ROE
Dividend Yield 2.40% 2.09%
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 41.0% (2nd %ile) 40.9% (5th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Distribution
6. R&D & Supply-Chain Moat IPAR
OpEx & R&D Intensity 41.9% of Rev ($629M) 35.5% of Rev ($709M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Household & Personal Products Operator Household & Personal Products Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: IPAR (7) vs EPC (3)
Institutional Metric IPAR EPC Criterion Row Edge
Market Capitalization
Scale
$4.2B $1.3B Larger Scale IPAR
Trailing P/E Ratio
Valuation
24.6x 14.5x Lower Multiple EPC
Forward P/E Ratio
Valuation
26.2x 13.8x Lower Multiple EPC
Revenue Growth (YoY)
Growth
+0.0% -9.9% Higher Growth IPAR
Operating Margin (TTM)
Profitability
17.9% 7.9% Higher Margin IPAR
Net Profit Margin
Profitability
11.3% -2.6% Higher Margin IPAR
Return on Equity (ROE)
Capital Efficiency
19.0% -0.1% Higher ROE IPAR
52-Week Range Position
Momentum
93% ($77–$138) 79% ($16–$30) Stronger Trend IPAR
Beta / 30D Volatility
Risk Regime
0.02β · 43% Vol 0.34β · 52% Vol Lower Realized Risk IPAR
Unified Institutional Score
Composite Signal
31.7 / 100 (SELL) 42.0 / 100 (HOLD) Higher Composite EPC
Trailing 12M Revenue (USD)
Operating Scale
$1.50B $2.00B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
59.8% 43.4% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
3.20x PEG · 2.8x EV/Rev 2.87x PEG · 0.7x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$293M EBITDA ($27.43 Book/Sh · 19.0% ROE) $235M EBITDA ($31.93 Book/Sh · -0.1% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon IPAR +18.06 pp
IPAR: +15.77% · EPC: -2.29%
3M Horizon IPAR +22.2 pp
IPAR: +18.05% · EPC: -4.15%
6M Horizon EPC +15.64 pp
IPAR: +53.32% · EPC: +68.96%
1Y Horizon IPAR +4.82 pp
IPAR: +53.11% · EPC: +48.29%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IPAR vs EPC. Trailing 12-month operating profitability (IPAR 17.9% vs EPC 7.9%) and valuation multiples (IPAR 26.2x vs EPC 13.8x Forward P/E) are benchmarked directly in Pillar 4 below.

IPAR ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.50B
Gross Margin59.8%
Op. Margin17.9%
ROE / Fwd P/E19.0% · 26.2x
EPC ADR TTM Benchmark FX-Normalized USD
TTM Revenue$2.00B
Gross Margin43.4%
Op. Margin7.9%
ROE / Fwd P/E-0.1% · 13.8x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
IPAR UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 41.0%
IV Percentile 2nd %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact IPAR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
EPC UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 40.9%
IV Percentile 5th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact EPC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
IPAR Moat Profile Scale & Operating Efficiency Moat
Household & Personal Products Operator
Competes within the Household & Personal Products value chain with $4.2B market capitalization and 17.9% operating margin.
OpEx & R&D Reinvestment 41.9% of Rev ($629M)
90D Engineering Disclosures 0 Published
EPC Moat Profile Cyclical / Execution-Driven Positioning
Household & Personal Products Operator
Competes within the Household & Personal Products value chain with $1.3B market capitalization and 7.9% operating margin.
OpEx & R&D Reinvestment 35.5% of Rev ($709M)
90D Engineering Disclosures 0 Published

Investor FAQ IPAR vs EPC Key Questions & Quantitative Answers

As of Nov 16, 2026, Interparfums, Inc. (IPAR) is the stronger overall head-to-head candidate over Edgewell Personal Care Company (EPC) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). IPAR carries a Unified Composite Score of 31.7/100 (SELL) at $133.94 (26.2x Forward P/E, 17.9% operating margin), whereas EPC carries 42.0/100 (HOLD) at $27.27 (13.8x Forward P/E, 7.9% operating margin). Composite vs. Pillar Nuance: While EPC currently prints a higher short-term Unified Composite Score (42.0/100 HOLD vs. IPAR 31.7/100 SELL), IPAR captures the overall institutional head-to-head verdict (7–3 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (17.9% vs. 7.9% operating margin) and revenue trajectory (+0.0% vs. -9.9% YoY). Technical & Structure Timing Caution: IPAR trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 68.9); meanwhile EPC is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 44.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

IPAR leads the Growth & Scale pillar: IPAR posts +0.0% YoY revenue growth and +3.9% YoY earnings growth on $1.50B TTM revenue (59.8% gross margin, 17.9% operating margin), compared with EPC at -9.9% YoY revenue growth and -53.4% YoY earnings growth on $2.00B TTM revenue (43.4% gross margin, 7.9% operating margin). On trailing 12-month operating scale, IPAR generates $1.50B in USD-normalized revenue versus $2.00B for EPC. In operating R&D and SG&A reinvestment, IPAR deploys 41.9% of Rev ($629M) (0 90-day corporate R&D disclosures) versus 35.5% of Rev ($709M) (0 disclosures) for EPC.

EPC screens cheaper on headline valuation multiples. IPAR trades at 26.2x Forward P/E, 24.6x Trailing P/E, 3.20x PEG, and 2.8x EV/Revenue (19.5% EBITDA margin), whereas EPC trades at 13.8x Forward P/E, 14.5x Trailing P/E, 2.87x PEG, and 0.7x EV/Revenue (11.8% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against IPAR (19.0% ROE) versus EPC (-0.1% ROE) capital efficiency.

In options market volatility and institutional positioning, IPAR carries 41.0% implied volatility (2nd %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.02β · 43% Vol realized risk). By comparison, EPC carries 40.9% implied volatility (5th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.34β · 52% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.